XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Carcinoma · Gastrointestinal Diseases · Stomach Cancer · Gastroesophageal-junction Cancer · Digestive System Diseases · Gastric Cancer · Gastrointestinal Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Jiangsu Province Hospital, Nanjing, Jiangsu, China
Contact: Study coordinator (Yongqian Shu, PhD) · shuyongqian@csco.org.cn · 00862568306428
Contact: Study coordinator (Xiaofeng Chen, PhD) · xiaofengch198019@126.com · 008613585172006

Study leads

Ext: Shu, PhD
Principal Investigator
The First Affiliated Hospital with Nanjing Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Pharmaceutical Management in Targeted Radioligand Therapy

Cancer · Thyroid Cancer · Metastatic Prostate Cancer

Abroad (travel likely)Recruiting

Bron, France · Dijon, France

Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

Renal Pelvis and Ureter Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States

Study of Aerobic Training for People Receiving Treatment for Breast Cancer

Breast Cancer · Breast Carcinoma

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States

[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

Head and Neck Squamous Cell Carcinoma HNSCC

Abroad (travel likely)RecruitingPHASE2

Lausanne, Switzerland